Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2020 Feb 13;105(11):2667–2670. doi: 10.3324/haematol.2019.235556

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2020 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 2. — Comparison of double hit in double expressor and non-double expressor (DE). (A-C) Within the DE group, the occurrence of a genetic double hit for MYC and BCL-2 (n=8 of 32, 25%) failed to confer a significant prognostic difference in EFS (P=0.628), PFS (P=0.375) and OS (P=0.059) between patients with DH positive and DH negative tumors. (D-F) Within the non DE group, the occurrence of a genetic double hit for MYC and BCL-2 (n=11 of 354, 3%) failed to confer a significant prognostic difference in EFS (P=0.099) and OS (P=0.222) between patients with DH positive and DH negative tumors.